Bowman & Co S.C. Sells 62 Shares of CME Group Inc. (NASDAQ:CME)

Bowman & Co S.C. decreased its holdings in CME Group Inc. (NASDAQ:CME) by 0.9% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,035 shares of the financial services provider’s stock after selling 62 shares during the period. CME Group accounts for about 0.9% of Bowman & Co S.C.’s portfolio, making the stock its 25th biggest holding. Bowman & Co S.C.’s holdings in CME Group were worth $1,515,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Second Half Financial Partners LLC purchased a new stake in shares of CME Group in the fourth quarter worth about $2,737,000. Naples Global Advisors LLC lifted its position in shares of CME Group by 5.6% in the fourth quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock worth $436,000 after buying an additional 110 shares in the last quarter. Sapient Capital LLC purchased a new stake in shares of CME Group in the fourth quarter worth about $1,823,000. Bluefin Capital Management LLC purchased a new stake in shares of CME Group in the fourth quarter worth about $2,891,000. Finally, FNY Investment Advisers LLC purchased a new stake in shares of CME Group in the fourth quarter worth about $1,074,000. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Barclays boosted their target price on CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 25th. Argus upped their price objective on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Morgan Stanley upped their price objective on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Keefe, Bruyette & Woods upped their target price on CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday, April 25th. Finally, JPMorgan Chase & Co. cut CME Group from a “neutral” rating to an “underweight” rating and dropped their price objective for the stock from $206.00 to $187.00 in a research note on Friday, June 21st. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $215.90.

Insider Activity

In other news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the sale, the director now owns 14,008 shares in the company, valued at approximately $2,821,771.52. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, Director Daniel R. Glickman sold 650 shares of the firm’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the transaction, the director now owns 14,008 shares in the company, valued at approximately $2,821,771.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 40,000 shares of the firm’s stock in a transaction on Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the completion of the transaction, the chief executive officer now owns 67,455 shares of the company’s stock, valued at approximately $14,226,934.05. The disclosure for this sale can be found here. In the last quarter, insiders sold 54,290 shares of company stock worth $11,393,700. Insiders own 0.30% of the company’s stock.

CME Group Stock Up 0.6 %

Shares of NASDAQ CME opened at $195.20 on Thursday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $70.29 billion, a PE ratio of 22.21, a price-to-earnings-growth ratio of 5.12 and a beta of 0.52. The stock’s fifty day simple moving average is $206.17 and its two-hundred day simple moving average is $208.97. CME Group Inc. has a 12-month low of $177.98 and a 12-month high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the prior year, the business posted $2.42 EPS. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. As a group, analysts expect that CME Group Inc. will post 9.75 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.36%. CME Group’s dividend payout ratio is presently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.